Can a shorter catheter reduce infections and clots?
NCT ID NCT06884176
First seen Jun 26, 2026 · Last updated Aug 28, 2026 · Updated 3 times
Summary
This study will compare two types of catheters—midline and central—in 100 adults who need a single vasopressor medication. The goal is to see if the shorter midline catheter leads to fewer bloodstream infections and blood clots. Participants will be randomly assigned to one catheter type and followed for 30 days.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If midline catheters cause fewer infections and blood clots, hospitals may switch to using them more often, improving patient safety.
- What could go wrong
- This is a small, early-stage study (100 patients) at one hospital, so results may not apply everywhere. The catheters are already in use, so no major new risks are expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients over 18 years of age being treated in the Emergency Department at Jacobi Medical Center * Have an upper extremity (left or right arm) that can accept a midline catheter * Able to provide consent (patient or health care proxy) * Clinical team believes the patient will require inpatient admission at the time of needing intravenous access * Requires a central line or midline catheter as an expected requirement of care * Patients requiring a single vasopressor due to hypotension Exclusion Criteria: * Patients in cardiac arrest (prior to achieving ROSC) * Patients with infection or burns at both upper extremities * Patient expected to be discharged from the hospital within 24 hours * Prisoner * Pregnancy * Children less than 18 years of age * The patient is known or is suspected to be allergic to materials contained in the device * Patients known to have bacteremia * Patients with existing central venous catheter * Patients without the ability to consent (or no health care proxy to consent)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Central venous catheter are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a longer IV catheter spare patients with difficult veins from repeated needle sticks?
- Can ultrasound predict difficult IV insertions before they happen?
- Common ICU procedure may briefly raise brain pressure — study investigates the risk
- Frail heart patients may need extra care for routine IV placement, study suggests
- Which dressing best protects skin from medical adhesive injury in ICU patients?
- Virtual nature walks may ease pain and fear during needle procedures